
LLY
Eli Lilly & Co.
$317.2
Open: $326 High: $330.85 Low: $322 Close: $329.71
Range: 2022-06-27 - 2022-06-28
Volume:1,032,778Market: Open
Powered by Finage Stock APIDelayed data
LLY
Eli Lilly & Co. LILLY CORPORATE CTR https://www.lilly.com
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.- CEO: David A. Ricks
- Employees: 35,000
- Sector: Healthcare
- Industry: Drug Manufacturers
LLY News
Latest news about the LLY
- The 10 Best Performing Stocks in the S&P 500 for 2021
Here're seven of the best performing stocks that saw record gains in the past 12 months
by Investor Place at 1/12/22, 12:00 AMView More → - 7 Pharmaceutical Stocks That Could Make You Rich
These seven pharmaceutical stocks could create lucrative opportunities in the new year
by Investor Place at 1/6/22, 12:00 AMView More →